ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

FENC Fennec Pharmaceuticals Inc

9.23
0.13 (1.43%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Fennec Pharmaceuticals Inc FENC NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.13 1.43% 9.23 07:00:52
始値 安値 高値 終値 前日終値
9.23 9.15 9.38 9.23 9.10
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/3/2119:00GLOBEFennec Pharmaceuticals Reports Full Year and Fourth Quarter..
2024/3/1919:01GLOBEFennec Pharmaceuticals to Report Full Year and Fourth..
2024/3/1816:00PRNUSFennec Pharmaceuticals and Norgine Enter into Exclusive..
2024/3/1810:00GLOBEFennec Pharmaceuticals and Norgine Enter into Exclusive..
2024/3/0706:07EDGAR2Form 8-K/A - Current report: [Amend]
2024/3/0106:04EDGAR2Form 8-K - Current report
2024/2/2921:04GLOBEFennec Pharmaceuticals Reports Preliminary Unaudited Net..
2024/2/1500:47EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/2/0119:55GLOBEFDA Issues Reminder of Non-Substitution of PEDMARK® (sodium..
2024/1/0607:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0606:45EDGAR2Form 144 - Report of proposed sale of securities
2024/1/0506:42EDGAR2Form 144 - Report of proposed sale of securities
2023/12/3006:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2905:51EDGAR2Form 144 - Report of proposed sale of securities
2023/12/1814:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/12/0519:55GLOBEFennec Announces Incremental $5 Million Investment from..
2023/11/1706:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1006:56EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/11/1006:52EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/1006:50GLOBEFennec Pharmaceuticals to Participate in Upcoming Investor..
2023/11/1006:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/0908:19EDGAR2Form 144 - Report of proposed sale of securities
2023/11/0619:59GLOBEFennec Pharmaceuticals Announces Third Quarter 2023..
2023/11/0406:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/3019:45GLOBEFennec Pharmaceuticals to Report Third Quarter 2023..
2023/9/0718:59GLOBEFennec Pharmaceuticals to Participate in Upcoming Investor..
2023/8/0806:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0805:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/0723:51EDGAR2Form 8-K/A - Current report: [Amend]
2023/8/0423:58EDGAR2Form 8-K - Current report
2023/8/0423:57EDGAR2Form 8-K - Current report
2023/8/0318:59GLOBEFennec Pharmaceuticals Announces Second Quarter 2023..
2023/7/3118:30GLOBEFennec Pharmaceuticals to Report Second Quarter 2023..
2023/7/0105:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/6/1306:00GLOBEFennec Announces Results of Annual Meeting
2023/6/0618:44GLOBEFennec Pharmaceuticals Announces European Commission..
2023/5/1119:01GLOBEFennec Pharmaceuticals Announces First Quarter 2023..
2023/5/0819:15GLOBEFennec Pharmaceuticals to Report First Quarter 2023..

最近閲覧した銘柄

Delayed Upgrade Clock